Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Biotech
Treasury COINS rules add biotech, spares China licensing deals
Despite the sweeping scope of the ban covering various drug modalities, biopharma business development teams can breathe a measured sigh of relief.
Angus Liu
Oct 22, 2026 11:36pm
Lexeo acquires Mantle for $8M, adding Friedreich ataxia assets
Sep 22, 2026 9:58am
Newly formed Jaguar acquires Afib device assets from J&J
Sep 15, 2026 11:11am
Fierce Pharma
Novartis investor calls for board overhaul after costly setbacks
Sep 10, 2026 10:26am
Fortrea boosts early-phase platform with $45M acquisition
Sep 2, 2026 3:06pm
Skye and Redx combine with $125M to advance fibrosis assets
Aug 14, 2026 2:05pm